logo
Plus   Neg
Share
Email

Infosys Says Didn't Receive Whistleblower Complaint

Infosys Ltd (INFY) clarified that it has not, till date, received the alleged anonymous whistleblower complaint through its whistleblower complaint reporting channels or from SEBI or the United States Securities and Exchange Commission and is therefore unable to comment on the complaint or the allegations made therein.

In the event the anonymous whistleblower complaint is received by the Company through its whistleblower complaint reporting channels or from SEBI or SEC, the company will deal with it in accordance with the Company's whistleblower policy, Infosys said.

Infosys said it has taken note of the media articles in relation to an alleged anonymous whistleblower complaint made to SEBI and United States Securities and Exchange Commission or "SEC" including the article titled "Whistleblower allegations unfounded: Shaw" appearing in Economic Times dated April 16, 2018.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT